Combination chemotherapeutic and immune-therapeutic anticancer approach via anti-PD-L1 antibody conjugated albumin nanoparticles.
Pham LM, Poudel K, Ou W, Phung CD, Nguyen HT, Nguyen BL, Karmacharya P, Pandit M, Chang JH, Jeong JH, Ku SK, Yong CS, Choi HG, Kim JO.
Pham LM, et al. Among authors: nguyen ht, nguyen bl.
Int J Pharm. 2021 Aug 10;605:120816. doi: 10.1016/j.ijpharm.2021.120816. Epub 2021 Jun 20.
Int J Pharm. 2021.
PMID: 34161810